lung cancer – Shamskm: A site to exchange knowledge and solutions

A blood test can predict early lung cancer prognosis

By Guest PostOctober 23, 2017Healthblood test, liquid biopsies, lung cancer, lung cancer patients, metastases, microfluidic chips, prognosis, rhonda jack, rishindra reddy, satellite tumors, sunitha nagrath, tumor removal surgery, vasudha murlidhar

ANN ARBOR — Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare, a team from the University of Michigan has shown. (more…)

Drug-resistant lung cancer may have Achilles heel

By Guest PostJune 11, 2015Healthachilles heel, behind the scenes, cast diversity, diversity problem, drug resistant, egfr, epidermal growth factor, lung cancer, michael helfenbein, people of color, receptor, yale university

Drugs introduced more than a decade ago that target mutations in a protein known as the epidermal growth factor receptor (EGFR) held the promise of personalized treatments for a common form of non-small cell lung cancer. But most patients quickly develop resistance to these drugs and are left with few or no treatment options, because it has been very difficult to design new drugs that act selectively upon the drug-resistant form. (more…)

Experimental drug shows encouraging results in treating most common form of lung cancer

By Guest PostNovember 15, 2013Healthamerican cancer society, australia, common form, drug related, edward garon, experimental drug, immunotherapy drug, kill cancer cell, lung cancer, merck, mk 3475, new drug, phase 1b study, protein pd1, side effects, sydney, treating, ucla, world conference

An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among men and women worldwide.

Dr. Edward Garon, director of thoracic oncology at UCLA’s Jonsson Comprehensive Cancer Center, presented the preliminary results of a Phase 1B study of the new drug, called MK-3475, on Oct. 29 at the World Conference on Lung Cancer in Sydney, Australia. (more…)

Old Habits Die Hard: Helping Cancer Patients Stop Smoking

By Guest PostNovember 26, 2012Healthann arbor, cancer diagnosis, death, familiar scene, hospital gowned patients, iv poles, lung cancer, medical campuses, nicotine addiction, program, quit smoking, smoking cigarettes, sonia duffy, treatment, university of michigan, va center

ANN ARBOR — It’s a sad but familiar scene near the grounds of many medical campuses: hospital-gowned patients, some toting rolling IV poles, huddled in clumps under bus shelters or warming areas, smoking cigarettes.

Smoking causes 30 percent of all cancer deaths and 87 percent of all lung cancer deaths. Yet, roughly 50 percent to 83 percent of cancer patients keep smoking after a cancer diagnosis, through treatment and beyond, says Sonia Duffy, University of Michigan School of Nursing researcher. For patients who quit on their own, relapse rates (as in the general population) are as high as 85 percent. (more…)

Surgical Treatment for Epilepsy Should Not be Viewed As a Last Resort, Study Shows

By Guest PostMarch 13, 2012Healthamerican, anti epileptic drug, brain surgery, breast cancer, cognitive problems, disability, epilepsy, harry vinters, itzhak fried, jerome engel, john stern, karl kieburtz, lung cancer, mesial temporal lobe epilepsy, sandra dewar, seizure, treatment

*Most patients wait until it’s too late to prevent serious disability*

While the thought of any type of surgery can be disconcerting, the thought of brain surgery can be downright frightening. But for people with a particular form of epilepsy, surgical intervention can literally be life-restoring.

Yet among people who suffer from what’s known as medically intractable epilepsy, in which seizures are resistant to drugs, only a small fraction will seek surgery, seeing it only as a last resort. As a result, they continue to suffer seizures year after year. They can’t drive, they can’t work and they lose cognitive function as the years pass. Premature death is not uncommon. (more…)

Nurses Key in Helping New Cancer Patients Overcome Fears

By Guest PostMarch 1, 2012Healthanti cancer treatment, anxiety, cancer death, diagnosis, distress, health care providers, key role, lung cancer, michigan state university, nurse, patient, patients, psychological adaptation, psychological distress, quality of life, rebecca h lehto, united states

EAST LANSING, Mich. — Often faced with overwhelming anxiety, patients newly diagnosed with lung cancer can find themselves in distress, and new research recommends nurses play a key role in alleviating concerns, leading to a better quality of life for patients.

A diagnosis of lung cancer – the leading cause of cancer death in the United States – brings with it high levels of stress and raises existential issues and death-related thoughts and concerns in patients, said Rebecca H. Lehto, assistant professor in the College of Nursing at Michigan State University. (more…)

Researchers Do Precise Gene Therapy Without A Needle

By Guest PostOctober 21, 2011Health, Scienceandrew morss, anti cancer gene, billionth of a meter, brian henslee, cell, early cancer detection and treatment, electrical pulses, fluorescent molecules, gene therapy, genetic pathways, gold coated dna strands, human cells, l james lee, leukemia cells, lung cancer, nanochannel electroporation, nanometer, nanometer sized channels, needle, nep, ohio state university, polymer stamps, polymeric device, pouyan boukany, reservoir of therapeutic agent, scale channel, therapeutic biomolecules, tumors, wei ching liao

COLUMBUS, Ohio – For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.

The technique uses electricity to “shoot” bits of therapeutic biomolecules through a tiny channel and into a cell in a fraction of a second.

L. James Lee and his colleagues at Ohio State University describe the technique in the online edition of the journal Nature Nanotechnology, where they report successfully inserting specific doses of an anti-cancer gene into individual leukemia cells to kill them. (more…)

UF Researchers Find Quiet Protein Speaks Loudly in Fight Against Cancer

By Guest PostMay 5, 2011Healthaubrey thompson, brahma, brm, cancer causing genes, cancer inhibiting properties, cancer therapy, carcinogens, cell adhesion, cells, david reisman, dna repair, geoffrey liu, hdac, histone deacetylase, lung cancer, oncogene, protein, race, sex, tumor growth, university of florida, university of toronto

GAINESVILLE, Fla. — When a movie character says, “It’s too quiet,” that’s usually a sign something bad may happen.

Now, University of Florida researchers have discovered that when variations of a certain protein in our cells are too quiet, it may add to the risk that someone will develop lung cancer. When scientists restored the protein to its normal, active self, its cancer-inhibiting properties reappeared. (more…)

Tag Archives: lung cancer